Treatment of choice of severe ITP is
Ans. b (IV gamma globulin). (Ref. Harrison, Principles of Medicine, 18th/Chapter 115.)IDIOPATHIC THROMBOCYTOPENIC PURPURA# Explosive onset of severe thrombocytopenia following recovery of viral exanthema or URI is common in children and accounts for 90% of paediatric immunologic thrombocytopenia.# 90% recover in 3-6 months.# Chronic ITP is common in females, 20-40 years of age.# Treatment include- glucocorticoids- danazol,- IV Ig or anti-RhD.- Emergency splenectomy depending on response to medical line of treatment is recommended.- Anti CD 20 abs (Rituximab) is also being tried in treatment of ITP.Initial treatment in patients without significant bleeding symptoms, severe thrombocytopenia (<5000/L), or signs of impending bleeding (such as retinal hemorrhage or large oral mucosal hemorrhages) can be instituted as an outpatient using single agents. Traditionally, this has been prednisone at 1 mg/kg, although Rh (D) immune globulin therapy (WinRho SDF), at 50-75 g/kg, is also being used in this setting.IVIgG has more efficacy than anti-Rh0(D) in postsplenectomized patients. IVIgG is dosed at 2 g/kg total, given in divided doses over 2-5 days.For patients with severe ITP and/or symptoms of bleeding, hospital admission and combined-modality therapy is given using high-dose glucocorticoids with IVIgG or anti-Rh D therapy, and, as needed, additional immunosuppressive agents. Rituximab, an anti-CD20 (B cell) antibody, has shown efficacy in the treatment of refractory ITP.Splenectomy has been used for treatment of patients who relapse after glucocorticoids are tapered.Thrombopoietin receptor agonists are now available for the treatment of ITP. Two agents, one administered subcutaneously (romiplostim) and another orally (eltrombopag), have shown response in many patients with refractory ITP.
BMT
IV gammaglobulins
Plasmapheresis
Steroids
Blood